Skip to main content

ACR2021 - Day4e

Nov 09, 2021 11:23 pm
Glucocorticoids and CV risk in RA: Drs. Aurelie Najm and Jon Giles Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay Rheumatic Diseases Can Take your Breath Away: Dr.Janet Pope Best of PsA Day 4 (Tuesday): MACE in PsA: Dr. Rachel Tate Predicting Progression from Psoriasis to PsA: Dr. Robert Chao David Liew Interview Dr. Seoyoung Kim About Tofacitinib and Malignancy Risk. Third Time's the Charm - COVID Vaccination While on Rituximab: Dr. Yuz Yusof Can We Stop Medication in Systemic JIA? Dr. Bella Mehta Day 4 SpA Highlights - Pregnancy in SpA and Drug Monitoring: Dr. Robert Chao

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×